Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Patterns and outcomes of invasive management of type 2 myocardial infarction in the United States

Patterns and outcomes of invasive management of type 2 myocardial infarction in the United States Background Type 2 myocardial infarction (MI) occurs due to a mismatch in myocardial oxygen supply and demand without unstable coronary artery disease. We sought to identify patterns, predictors and outcomes of invasive management of type 2 MI in the USA. Methods Adults aged ≥18 years hospitalized with type 2 MI were identified in a cross-sectional study from the 2018 National Inpatient Sample. Invasive management was defined as invasive coronary angiography or revascularization. Patient, hospital and geographic characteristics associated with invasive management were identified by multivariable logistic regression. Propensity-matched cohorts were generated to evaluate associations between invasive vs. conservative management and mortality. Results We identified 268 850 admissions with type 2 MI in 2018. Type 2 MI patients had a high burden of comorbidities and were commonly admitted with diagnoses of circulatory (39.7%), infectious (23.1%) or respiratory (10.8%) illness. Only 11.2% of type 2 MI were managed invasively, of which 17.9% underwent coronary revascularization. Odds of invasive management were higher with commercial insurance [adjusted OR (aOR) 1.39; 95% confidence interval (CI), 1.27–1.52] and lower with Medicaid (aOR 0.86; 95% CI, 0.76–0.96) vs. Medicare. Significant heterogeneity in invasive management of type 2 MI was observed by geographic region (range 7.2–13.8%), independent of patient and hospital factors. Invasive management was associated with lower in-hospital mortality than conservative management overall (3.9 vs. 9.1%; P < 0.001) and in propensity-matched analyses (OR, 0.70; 95% CI, 0.59–0.84). Conclusion Invasive management of type 2 MI varies by insurance status and geography, highlighting uncertainty regarding optimal management and potential disparities in clinical care. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Anti-Cancer Drugs Wolters Kluwer Health

Patterns and outcomes of invasive management of type 2 myocardial infarction in the United States

Download PDF
8 pages

Loading next page...
 
/lp/wolters-kluwer-health/patterns-and-outcomes-of-invasive-management-of-type-2-myocardial-XVXekeJQ50

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wolters Kluwer Health
Copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
ISSN
0959-4973
eISSN
1473-5741
DOI
10.1097/mca.0000000000001122
Publisher site
See Article on Publisher Site

Abstract

Background Type 2 myocardial infarction (MI) occurs due to a mismatch in myocardial oxygen supply and demand without unstable coronary artery disease. We sought to identify patterns, predictors and outcomes of invasive management of type 2 MI in the USA. Methods Adults aged ≥18 years hospitalized with type 2 MI were identified in a cross-sectional study from the 2018 National Inpatient Sample. Invasive management was defined as invasive coronary angiography or revascularization. Patient, hospital and geographic characteristics associated with invasive management were identified by multivariable logistic regression. Propensity-matched cohorts were generated to evaluate associations between invasive vs. conservative management and mortality. Results We identified 268 850 admissions with type 2 MI in 2018. Type 2 MI patients had a high burden of comorbidities and were commonly admitted with diagnoses of circulatory (39.7%), infectious (23.1%) or respiratory (10.8%) illness. Only 11.2% of type 2 MI were managed invasively, of which 17.9% underwent coronary revascularization. Odds of invasive management were higher with commercial insurance [adjusted OR (aOR) 1.39; 95% confidence interval (CI), 1.27–1.52] and lower with Medicaid (aOR 0.86; 95% CI, 0.76–0.96) vs. Medicare. Significant heterogeneity in invasive management of type 2 MI was observed by geographic region (range 7.2–13.8%), independent of patient and hospital factors. Invasive management was associated with lower in-hospital mortality than conservative management overall (3.9 vs. 9.1%; P < 0.001) and in propensity-matched analyses (OR, 0.70; 95% CI, 0.59–0.84). Conclusion Invasive management of type 2 MI varies by insurance status and geography, highlighting uncertainty regarding optimal management and potential disparities in clinical care.

Journal

Anti-Cancer Drugs – Wolters Kluwer Health

Published: Jun 17, 2022

References

  • Fourth Universal Definition of Myocardial Infarction (2018).
    Thygesen, K; Alpert, JS; Jaffe, AS; Chaitman, BR; Bax, JJ; Morrow, DA; White, HD
  • 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Amsterdam, EA; Wenger, NK; Brindis, RG; Casey, DE; Ganiats, TG; Holmes, DR
  • Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury.
    Chapman, AR; Shah, ASV; Lee, KK; Anand, A; Francis, O; Adamson, P
  • Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction.
    Smilowitz, NR; Subramanyam, P; Gianos, E; Reynolds, HR; Shah, B; Sedlis, SP
  • Patient characteristics and clinical outcomes of type 1 versus type 2 myocardial infarction.
    McCarthy, CP; Kolte, D; Kennedy, KF; Vaduganathan, M; Wasfy, JH; Januzzi, JL
  • Incidence, trends, and outcomes of type 2 myocardial infarction in a community cohort.
    Raphael, CE; Roger, VL; Sandoval, Y; Singh, M; Bell, M; Lerman, A
  • Classification of myocardial infarction: frequency and features of type 2 myocardial infarction.
    Saaby, L; Poulsen, TS; Hosbond, S; Larsen, TB; Pyndt Diederichsen, AC; Hallas, J
  • Type-II myocardial infarction–patient characteristics, management and outcomes.
    Stein, GY; Herscovici, G; Korenfeld, R; Matetzky, S; Gottlieb, S; Alon, D
  • Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction.
    Hung, J; Roos, A; Kadesjo, E
  • Regional variation across the United States in management and outcomes of ST-elevation myocardial infarction: analysis of the 2003 to 2010 nationwide inpatient sample database.
    Kolte, D; Khera, S; Aronow, WS; Mujib, M; Palaniswamy, C; Ahmed, A
  • Geographic variation in the treatment of acute myocardial infarction: the Cooperative Cardiovascular Project.
    O’Connor, GT; Quinton, HB; Traven, ND; Ramunno, LD; Dodds, TA; Marciniak, TA; Wennberg, JE
  • Insurance status and the treatment of myocardial infarction at academic centers.
    Hiestand, BC; Prall, DM; Lindsell, CJ; Hoekstra, JW; Pollack, CV; Hollander, JE
  • Payer status and the utilization of hospital resources in acute myocardial infarction: a report from the National Registry of Myocardial Infarction 2.
    Canto, JG; Rogers, WJ; French, WJ; Gore, JM; Chandra, NC; Barron, HV
  • Angiographic correlates in type 1 and 2 MI by the universal definition.
    Ambrose, JA; Loures-Vale, A; Javed, U; Buhari, CF; Aftab, W
  • Effect of a proposed modification of the type 1 and type 2 myocardial infarction definition on incidence and prognosis.
    Schoepfer, H; Nestelberger, T; Boeddinghaus, J; Twerenbold, R; Lopez-Ayala, P; Koechlin, L
  • The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): a randomized trial design.
    Lambrakis, K; French, JK; Scott, IA; Briffa, T; Brieger, D; Farkouh, ME
  • Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes.
    Botto, F; Alonso-Coello, P; Chan, MT; Villar, JC; Xavier, D; Srinathan, S
  • Effect of definition on incidence and prognosis of type 2 myocardial infarction.
    Nestelberger, T; Boeddinghaus, J; Badertscher, P; Twerenbold, R; Wildi, K; Breitenbücher, D
  • Cardiologist evaluation of patients with type 2 myocardial infarction.
    McCarthy, CP; Olshan, DS; Rehman, S; Jones-O’Connor, M; Murphy, S; Cohen, JA
  • Cardiovascular mortality after type 1 and type 2 myocardial infarction in young adults.
    Singh, A; Gupta, A; DeFilippis, EM; Qamar, A; Biery, DW; Almarzooq, Z